Insider trades
Franklin M. Berger, Director of Atea Pharmaceuticals AVIR, has filed 5 purchases and 8 sales on the open market. The latest trade was on 06/18.
Franklin M. Berger
Director
- Company
- Atea Pharmaceuticals AVIR
- First filing
- 23/01/05
- Trades
- 50 trades
- Buys / sales
- 5 / 8
- 12-month net buying
- No record
- Last trade
- 06/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AVIR | Open-market buyAmendment | 25/01/15–25/01/16 | 25/01/17 | 50,000 sh4 trades | $3.26avg. | $162,900 | No record |
| Open-market sale | 24/12/10 | 24/12/12 | 359,606 sh | $2.85 | $1,024,877.1 | −44.3% | |
| Open-market buy | 23/11/21 | 23/11/22 | 23,259 sh | $5.73 | $133,274.07 | +3.1% | |
| Open-market buy | 23/11/02–23/11/03 | 23/11/16 | 76,471 sh2 trades | $5.49avg. | $419,661.29 | +11.2% | |
| Open-market sale | 22/12/14–22/12/21 | 23/01/05 | 272,840 sh7 trades | $2.67avg. | $729,051.78 | −28.5% |